Patient’s Perspectives of Experimental HCV-Positive to HCV-Negative Renal Transplantation: Report from a Single Site

References

• Annas, G. J. 2017. Cure research and consent: The Mississippi Baby, Barney Clark, Baby Fae and Martin Delaney. Journal of Medical Ethics 43 (2):104. doi: 10.1136/medethics-2015-103121.
   PubMed Web of Science ®Google Scholar
• Bowring, M. G., Kucirka, L. M. A. B. Massie, X. Luo, A. Cameron, M. Sulkowski, K. Rakestraw, A. Gurakar, I. Kuo, D. L. Segev, C. M., et al. 2017. Changes in utilization and discard of hepatitis C–infected donor livers in the recent era. American Journal of Transplantation 17 (2):519–27. doi: 10.1111/ajt.13976.
   PubMed Web of Science ®Google Scholar
• Burstow, N. J., Z. Mohamed, A. I. Gomaa, M. W. Sonderup, N. A. Cook, I. Waked, C. W. Spearman, and S. D. Taylor-Robinson. 2017. Hepatitis C treatment: Where are we now? International Journal of General Medicine 10:39–52. doi: 10.2147/IJGM.S127689.
   PubMed Web of Science ®Google Scholar
• Chafe, R. 2017. The value of qualitative description in health services and policy research. Healthcare Policy = Politiques de Sante 12 (3):12–8.
   PubMedGoogle Scholar
• Chen, K., P. Lu, R. Song, J. Zhang, R. Tao, Z. Wang, W. Zhang, and M. Gu. 2017. Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection: A PRISMA-compliant study. Medicine 96 (30):e7568. doi: 10.1097/MD.0000000000007568.
   PubMed Web of Science ®Google Scholar
• Chute, D. F., and M. E. Sise. 2018. Effect of the opioid crisis on the donor pool for kidney transplantation: An analysis of national kidney deceased donor trends from 2010–2016. American Journal of Nephrology 47 (2):84–93. doi: 10.1159/000486516.
   PubMed Web of Science ®Google Scholar
• clinicaltrials.gov. Exploring renal transplants using hepatitis C infected donors for HCV-negative recipients (EXPANDER-1). Accessed April 04, 2018. https://clinicaltrials.gov/ct2/show/NCT02781649.
   Google Scholar
• Colombo, M., A. Aghemo, H. Liu, J. Zhang, H. Dvory-Sobol, R. Hyland, C. Yun, B. Massetto, D. M. Brainard, J. G. McHutchison, et al. 2017. Treatment with ledipasvir–sofosbuvir for 12 or 24 weeks in kidney transplant recipients with chronic hepatitis C virus genotype 1 or 4 infection. Annals of Internal Medicine 166 (2):109–17. doi: 10.7326/M16-1205.
   PubMed Web of Science ®Google Scholar
• Cooper, J., I. Blake, J. O. Lindsay, and C. J. Hawkey. 2017. Living with Crohn's disease: An exploratory cross-sectional qualitative study into decision-making and expectations in relation to autologous haematopoietic stem cell treatment (the DECIDES study). BMJ Open 7 (9):e015201. doi: 10.1136/bmjopen-2016-015201.
   PubMed Web of Science ®Google Scholar
• Cote, D. J., A. L. Bredenoord, T. R. Smith, M. Ammirati, J. Brennum, I. Mendez, A. S. Ammar, N. Balak, G. Bolles, I. N. Esene, et al. 2017. Ethical clinical translation of stem cell interventions for neurologic disease. Neurology 88 (3):322–328. doi: 10.1212/WNL.0000000000003506.
   PubMed Web of Science ®Google Scholar
• Dew, M. A., G. E. Switzer, J. M. Goycoolea, A. S. Allen, A. DiMartini, R. L. Kormos, and B. P. Griffith. 1997. Does transplantation produce quality of life benefits? A quantitative analysis of the literature. Transplantation 64 (9):1261–73. doi: 10.1097/00007890-199711150-00006.
   PubMed Web of Science ®Google Scholar
• Durand, C. M., M. G. Bowring, D. M. Brown, M. A. Chattergoon, G. Massaccesi, N. Bair, R. Wesson, A. Reyad, F. F. Naqvi, D. Ostrander, et al. 2018. Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus–infected donors to noninfected recipients: An open-label nonrandomized trial. Annals of Internal Medicine 168 (8):533–540. doi: 10.7326/M17-2871.
   PubMed Web of Science ®Google Scholar
• Foster, G. R., Agarwal, K. M. E. Cramp, S. Moreea, S. Barclay, J. Collier, A. S. Brown, S. D. Ryder, A. Ustianowski, D. M. Forton, R., et al. 2017. Elbasvir/grazoprevir plus sofosbuvir in treatment-naive and treatment-experienced cirrhotic patients with hepatitis C virus genotype 3 infection treated for 8, 12, or 16 weeks: Final results of the C-ISLE study. Journal of Hepatology 66 (1):S503–S504. doi: 10.1016/S0168-8278(17)31407-1.
   Web of Science ®Google Scholar
• Goldberg, D. S., Abt, P. L. E. A. Blumberg, V. M. Van Deerlin, M. Levine, K. R. Reddy, R. D. Bloom, S. M. Nazarian, D. Sawinski, P. Porrett, A. Naji. 2017. Trial of transplantation of HCV-infected kidneys into uninfected recipients. New England Journal of Medicine 376 (24):2394–5. doi: 10.1056/NEJMc1705221.
   PubMed Web of Science ®Google Scholar
• Gross, C. R., C. Limwattananon, B. Matthees, J. L. Zehrer, and K. Savik. 2000. Impact of transplantation on quality of life in patients with diabetes and renal dysfunction. Transplantation 70 (12):1736–46. doi: 10.1097/00007890-200012270-00013.
   PubMed Web of Science ®Google Scholar
• Henderson, M., S. Rasmussen, and J. Sugarman. 2017. Advancing HIV care and transplantation: Ethical, legal, and social issues at the center of HIV + to HIV + solid organ transplants. American Society for Bioethics and Humanities, Kansas City, MO.
   Google Scholar
• Horng, Sam, and Christine Grady. 2003. Misunderstanding in clinical research: Distinguishing therapeutic misconception, therapeutic misestimation, & therapeutic optimism. IRB: Ethics and Human Research 25 (1):11–6. doi: 10.2307/3564408.
   PubMedGoogle Scholar
• Jofre, R., J. M. Lopez-Gomez, F. Moreno, D. Sanz-Guajardo, and F. Valderrabano. 1998. Changes in quality of life after renal transplantation. American Journal of Kidney Diseases 32 (1):93–100. doi: 10.1053/ajkd.1998.v32.pm9669429.
   PubMed Web of Science ®Google Scholar
• Kass, N. E., J. Sugarman, A. M. Medley, L. A. Fogarty, H. A. Taylor, C. K. Daugherty, M. R. Emerson, S. N. Goodman, F. J. Hlubocky, H. I. Hurwitz, and M. Carducci. 2009. An intervention to improve cancer patients' understanding of early-phase clinical trials . IRB 31 (3):1–10.
   PubMedGoogle Scholar
• Katz, A. W. K., B. S. Mensch, K. Woeber, P. Musara, J. Etima, and A. van der Straten. 2019. Understanding women's motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence. BMC Women's Health 19 (1):18. doi: 10.1186/s12905-019-0713-6.
   PubMedGoogle Scholar
• King, N. M. P. 2000. Defining and describing benefit appropriately in clinical trials. The Journal of Law, Medicine & Ethics 28 (4):332–43. doi: 10.1111/j.1748-720X.2000.tb00685.x.
   PubMed Web of Science ®Google Scholar
• Kucirka, L. M., A. L. Singer, R. L. Ros, R. A. Montgomery, N. N. Dagher, and D. L. Segev. 2010. Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients. American Journal of Transplantation 10 (5):1238–46. doi: 10.1111/j.1600-6143.2010.03091.x.
   PubMed Web of Science ®Google Scholar
• Lawitz, E., F. Poordad, J. A. Gutierrez, J. T. Wells, C. E. Landaverde, B. Evans, A. Howe, H. C. Huang, J. J. Li, P. Hwang, and F. J. Dutko. 2017. Short-duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trial. Hepatology 65 (2):439–50. doi: 10.1002/hep.28877.
   PubMed Web of Science ®Google Scholar
• Lee, S. L., J. A. Anesi, B. D. Besharatian, T. Bittermann, S. Hamel, and D. S. Goldberg. 2018. Con: Use of Hepatitis C Virus-Positive donors should be restricted to research protocols. Clinical Liver Disease 12 (4):105–108. doi: 10.1002/cld.744.
   Google Scholar
• Levitsky, J., Formica, R. N. R. D. Bloom, M. Charlton, M. Curry, J. Friedewald, J. Friedman, D. Goldberg, S. Hall, M. Ison, T., et al. 2017. The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation. American Journal of Transplantation 11:2790–802. doi: 10.1111/ajt.14381.
   Google Scholar
• Lin, M. V., M. E. Sise, M. Pavlakis, B. M. Amundsen, D. Chute, A. E. Rutherford, R. T. Chung, M. P. Curry, J. M. Hanifi, S. Gabardi, and A. Chandraker. 2016. Efficacy and safety of direct acting antivirals in kidney transplant recipients with chronic hepatitis C virus infection. PloS One 11 (7):e0158431. doi: 10.1371/journal.pone.0158431.
   PubMed Web of Science ®Google Scholar
• Neergaard, M. A., F. Olesen, R. S. Andersen, and J. Sondergaard. 2009. Qualitative description – the poor cousin of health research? BMC Medical Research Methodology 9 (1):52. doi: 10.1186/1471-2288-9-52.
   PubMed Web of Science ®Google Scholar
• Peay, H. L., and G. E. Henderson. 2015. What motivates participation in HIV cure trials? A call for real-time assessment to improve informed consent. Journal of Virus Eradication 1 (2):51–3.
   PubMedGoogle Scholar
• Petrini, C., S. Gainotti, A. Morresi, and A. Nanni Costa. 2017. Ethical issues in uterine transplantation: Psychological implications and informed consent. Transplantation Proceedings 49 (4):707–10. doi: 10.1016/j.transproceed.2017.02.013.
   PubMed Web of Science ®Google Scholar
• Rana, A., A. Gruessner, V. G. Agopian, Z. Khalpey, I. B. Riaz, B. Kaplan, K. J. Halazun, R. W. Busuttil, and R. W. G. Gruessner. 2015. Survival benefit of solid-organ transplant in the United States. JAMA Surgery 150 (3):252–259. doi: 10.1001/jamasurg.2014.2038.
   PubMed Web of Science ®Google Scholar
• Reese, P. P., P. L. Abt, E. A. Blumberg, V. M. Van Deerlin, R. D. Bloom, V. S. Potluri, M. Levine, P. Porrett, D. Sawinski, S. M. Nazarian, et al. 2018. Twelve-month outcomes after transplant of hepatitis C–infected kidneys into uninfected recipients: A single-group trial. Annals of Internal Medicine 169 (5):273–81. doi: 10.7326/M18-0749.
   PubMed Web of Science ®Google Scholar
• Reese, P. P., J. Shults, R. D. Bloom, A. Mussell, M. N. Harhay, P. Abt, M. Levine, K. L. Johansen, J. T. Karlawish, and H. I. Feldman. 2015. Functional status, time to transplantation, and survival benefit of kidney transplantation among wait-listed candidates. American Journal of Kidney Diseases 66 (5):837–45. doi: 10.1053/j.ajkd.2015.05.015.
   PubMed Web of Science ®Google Scholar
• Saxena, V., V. Khungar, E. C. Verna, J. Levitsky, R. S. Brown, Jr., M. A. Hassan, M. S. Sulkowski, J. G. O'Leary, F. Koraishy, J. S. Galati, A. A. Kuo. 2017. Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study. Hepatology 66 (4):1090–1101. doi: 10.1002/hep.29258.
   PubMed Web of Science ®Google Scholar
• Schold, J. D., L. D. Buccini, D. A. Goldfarb, S. M. Flechner, E. D. Poggio, and A. R. Sehgal. 2014. Association between kidney transplant center performance and the survival benefit of transplantation versus dialysis. Clinical Journal of the American Society of Nephrology 9 (10):1773–80. doi: 10.2215/CJN.02380314.
   PubMed Web of Science ®Google Scholar
• Sugarman, J., P. W. Lavori, M. Boeger, C. Cain, R. Edson, V. Morrison, and S. S. Yeh. 2005. Evaluating the quality of informed consent. Clinical Trials: Journal of the Society for Clinical Trials 2 (1):34–41. doi: 10.1191/1740774505cn066oa.
   Google Scholar
• Tonelli, M., N. Wiebe, G. Knoll, A. Bello, S. Browne, D. Jadhav, S. Klarenbach, and J. Gill. 2011. Systematic review: Kidney transplantation compared with dialysis in clinically relevant outcomes. American Journal of Transplantation 11 (10):2093–109. doi: 10.1111/j.1600-6143.2011.03686.x.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health & Human Services Organ Procurement and Transplantation Network Data. 2018. Current U.S. Waiting List Candidates by Organ. Richmond, VA.
   Google Scholar
• Werbel, W. A., and C. M. Durand. 2018. Pro: Use of Hepatitis C Virus-Positive donors should be considered standard of care. Clinical Liver Disease 12 (4):100–104. doi: 10.1002/cld.743.
   Google Scholar